Crestline Management’s Monsanto Co MON Stock Holding History

Crestline Management’s Portfolio MON Stock Details MON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-53,000	Closed	-$6.27M	–	195
2017 Q2	$6.27M	Buy	+53,000	New	+$6.18M	0.84%	4

Other funds holding MON

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Crestline Management's MON Position: Q3 2017 in Review

Crestline Management sold out of Monsanto Co (MON) in Q3 2017, closing a stake of 53,000 shares — an estimated $6.27M sold.

Crestline Management first reported a position in MON in Q2 2017 and held it in 1 quarter. The position peaked at $6.27M in Q2 2017. 1,033 funds tracked by Wall St. Rank hold MON as of Q3 2017.

Crestline Management reported no remaining Monsanto Co position as of Q3 2017 after selling out during the quarter.
Crestline Management sold 53,000 Monsanto Co shares in Q3 2017, an estimated $6.27M.
Crestline Management first reported a position in Monsanto Co in Q2 2017 and held it in 1 quarter.
Crestline Management's Monsanto Co position peaked at $6.27M in Q2 2017.
1,033 funds tracked by Wall St. Rank held Monsanto Co as of Q3 2017.

Based on Crestline Management's 13F filing for Q3 2017, filed 14 Nov 2017.